(141 days)
Implant Studio™ is indicated for use as a medical front-end software that can be used by medically trained professionals for the purpose of visualizing gray value images. It is intended for use as a pre-operative planning software for the placement of dental implant(s) based on imported CT image data, optionally aligned to an optical 3D surface scan. Virtual Crowns can be used for optimized implant positioning under the prosthetic aspect. The digital three dimensional model of a surgical guide for a guided surgery can be designed based on the approved implant position. This 3D data can be exported to manufacture a separate physical product.
Indications of the dental implants do not change with guided surgery compared to conventional surgery.
Use of the software requires that the user has the necessary medical training in implantology and surgical dentistry.
Implant Studio™ is a software only device used to pre-operatively plan the placement of a dental implant and to visualize a patient's CT image, optionally aligned to an optical 3D surface data. Virtual crown(s) can be used to quide the planning under the final prosthetic aspect. The surgical guide data can be designed then exported to an external system for manufacturing.
The device has no patient contact.
The provided text describes the 3Shape Implant Studio, a medical planning software. However, it does not contain a detailed study with acceptance criteria and reported device performance in a table format.
Here's an analysis of the available information:
1. Table of Acceptance Criteria and Reported Device Performance:
The document states: "Prior to release, verification and validation testing of the Implant Studio has been completed using the approved acceptance criteria: Each user need has its own validation acceptance criteria: each specification has its own verification acceptance criteria; bug verification consists in ensuring issue is not reproducible; issues reported by beta partners must be reviewed and handled appropriately."
However, no specific quantitative acceptance criteria or corresponding reported device performance metrics are provided in a table or any other format within the given text. It mentions that "All test results have been reviewed and approved, showing the Implant Studio to be substantially equivalent in safety and effectiveness to the predicate," but lacks concrete data.
2. Sample size used for the test set and the data provenance:
- Sample size: Not specified.
- Data provenance: Not specified. The document only mentions "bug verification consists in ensuring issue is not reproducible; issues reported by beta partners must be reviewed and handled appropriately," which suggests some testing with external users, but the origin or nature of the data involved is not detailed.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
This information is not provided. The text does not detail how ground truth was established for any internal testing or beta testing.
4. Adjudication method for the test set:
Not specified.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
No MRMC study was mentioned. The document focuses on the software as a planning tool, not as an AI-assissted diagnostic or interpretive device.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
The device is described as "software only device used to pre-operatively plan the placement of a dental implant and to visualize a patient's CT image... The guide can be used for aiding the placement of the implant(s) to the intended position(s)." It appears to be an algorithm-only device for planning, but its performance is not explicitly presented as a standalone study result. The "use of the software requires that the user has the necessary medical training in implantology and surgical dentistry," indicating a human-in-the-loop for the overall process, even if the planning itself is algorithmically driven. However, there's no standalone performance study reported.
7. The type of ground truth used:
Not specified in the provided text.
8. The sample size for the training set:
The document does not mention a "training set" in the context of machine learning or AI. It refers to a "planning phase" and "library files," but no training data for an algorithm is described.
9. How the ground truth for the training set was established:
This information is not applicable as no training set is discussed. The "implant and sleeve library files are provided via encrypted library files which are generated by 3Shape and approved by the corresponding original manufactures," suggesting pre-defined data rather than a learned model.
In summary, the provided FDA 510(k) summary focuses on establishing substantial equivalence to predicate devices and describes the software's intended use, technological characteristics, and verification/validation processes. However, it does not include the specific quantitative acceptance criteria, detailed study designs, sample sizes, or ground truth establishment methods that would fully answer the questions posed. The nonclinical testing section broadly states that "verification and validation testing... has been completed using the approved acceptance criteria," but these criteria and their results are not explicitly detailed. The document also explicitly states: "Clinical testing is not a requirement and has not been performed."
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a stylized eagle with three heads, representing the department's commitment to health, human services, and the USA. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
October 31, 2014
3Shape Medical A/S % Ms. Hanne Nielsen Regulatory Affairs Manager Holmens Kanal 7 DK-1060 Copenhagen K DENMARK
Re: K141570
Trade/Device Name: Implant Studio Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: October 10, 2014 Received: October 14, 2014
Dear Ms. Nielsen:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{1}------------------------------------------------
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Smh.p)
for
Janine M. Morris Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K141570
Device Name Implant Studio
Implant Studio™ is indicated for use as a medical front-end software that can be used by medically trained professionals for the purpose of visualizing gray value images. It is intended for use as a pre-operative planning software for the placement of dental implant(s) based on imported CT image data, optionally aligned to an optical 3D surface scan. Virtual Crowns can be used for optimized implant positioning under the prosthetic aspect. The digital three dimensional model of a surgical guide for a guided surgery can be designed based on the approved implant position. This 3D data can be exported to manufacture a separate physical product.
Indications of the dental implants do not change with guided surgery compared to conventional surgery. Use of the software requires that the necessary medical training in implantology and surgical dentistry.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Druq Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
510(K) SUMMARY - Traditional 510(K)
Submitter Information
| A Company Name: | 3Shape Medical A/S |
|---|---|
| B Company Address: | Holmens Kanal 7DK-1060 Copenhagen K |
| C Company Phone:Company Fax: | +45 7027 2620+45 7027 2621 |
| D Contact Person: | Hanne NielsenRegulatory Affairs Manager |
| E Date Summary Prepared: | May 28, 2014 |
| Device Identification | |
| A Trade/proprietary Name: | Implant Studio™ |
| B Common Name: | Implant Planning and Surgical Guide |
| C Device Classification Name: | Picture archiving and communications |
system C Regulation Number: 892.2050 C Classification: Class II D Product Code: LLZ
Predicate Device
The 3Shape Implant Studio™ Software has the same intended uses and major functions as Dentsply Simplant 2011 (K110300) and Straumann AG coDiagnostix (K130724). Testing demonstrates the implementation functions as intended, and differences between the Device and the predicates do not raise additional concerns with the Device's safety and effectiveness.
Indications for Use/Intended Use
Implant Studio™ is indicated for use as medical front-end software that can be used by medically trained professionals for the purpose of visualizing gray value images. It is intended for use as pre-operative planning software for the placement of dental implant(s) based on imported CT image data, optionally aligned to an optical 3D surface scan. Virtual Crowns can be used for optimized implant positioning under the prosthetic aspect. The digital three dimensional model of a surgical guide for a
{4}------------------------------------------------
3shape
guided surgery can be designed based on the approved implant position. This 3D data can be exported to manufacture a separate physical product.
Indications of the dental implants do not change with guided surgery compared to conventional surgery.
Use of the software requires that the user has the necessary medical training in implantology and surgical dentistry.
Device Description
Implant Studio™ is a software only device used to pre-operatively plan the placement of a dental implant and to visualize a patient's CT image, optionally aligned to an optical 3D surface data. Virtual crown(s) can be used to quide the planning under the final prosthetic aspect. The surgical guide data can be designed then exported to an external system for manufacturing.
The device has no patient contact.
Scientific Concept
The underlying scientific concept is the visualization of an imported CT image from DICOM data to pre-operatively analyze and plan the placement of dental implant(s) in the maxilla and/or mandible region by taking the prosthetic and clinical requirements into consideration. Optionally, the CT image can be aligned to optical 3D surface scan data. The implant and sleeve library files are provided via encrypted library files which are generated by 3Shape and approved by the corresponding original manufactures. CAD designed virtual crown(s) can be used to assist during the planning phase. Moreover, the use of CAD design technology allows the design of a surqical quide, which can be exported to a 30 party manufacturing device. The quide can be used for aiding the placement of the implant(s) to the intended position(s). PDF reports are generated to document the planning information and to provide an overview of the required surgical components.
Summary of the technological characteristics
Implant Studio™ is a software only device programmed in C# and has the following PC/laptop hardware requirements:
| Item | Minimum Requirements |
|---|---|
| OS: | Windows 7 or 8 64-bit |
| RAM: | 8GB or better |
| Monitor Resolution: | 1280x800 or higher |
| Video Card Memory: | 1GB GeForce or better |
| Available HDD Space: | 250GB |
| CPU: | IntelCore i5 or higher |
{5}------------------------------------------------
| Network: | Network Internet connection |
|---|---|
| Mouse: | With the wheel button |
ssha
Nonclinical Testing
Software, hardware, and integration verification and validation testing was performed in accordance with the FDA Guidance Document "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices" (Issued on May 11, 2005).
Prior to release, verification and validation testing of the Implant Studio has been completed using the approved acceptance criteria: Each user need has its own validation acceptance criteria: each specification has its own verification acceptance criteria; bug verification consists in ensuring issue is not reproducible; issues reported by beta partners must be reviewed and handled appropriately.
The validation suite includes validation of implemented mitigations related to device hazards identified in the risk management procedures.
All test results have been reviewed and approved, showing the Implant Studio to be substantially equivalent in safety and effectiveness to the predicate.
Clinical Testing
Clinical testing is not a requirement and has not been performed.
Conclusion
Based on a comparison of intended use, indications, principle of operations, features and technical data, and the test results, the Implant Studio is found to be substantially equivalent in safety and effectiveness to the predicate. Intended use and performance is found to be substantially equivalent to the Predicate Devices.
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).